» Articles » PMID: 24339057

Increased IL-6 Expression in Osteoclasts is Necessary but Not Sufficient for the Development of Paget's Disease of Bone

Overview
Date 2013 Dec 17
PMID 24339057
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Measles virus nucleocapsid protein (MVNP) expression in osteoclasts (OCLs) and mutation of the SQSTM1 (p62) gene contribute to the increased OCL activity in Paget's disease (PD). OCLs expressing MVNP display many of the features of PD OCLs. Interleukin-6 (IL-6) production is essential for the pagetic phenotype, because transgenic mice with MVNP targeted to OCLs develop pagetic OCLs and lesions, but this phenotype is absent when MVNP mice are bred to IL-6(-/-) mice. In contrast, mutant p62 expression in OCL precursors promotes receptor activator of NF-κB ligand (RANKL) hyperresponsivity and increased OCL production, but OCLs that form have normal morphology, are not hyperresponsive to 1,25-dihydroxyvitamin D3 (1,25-(OH)2 D3 ), nor produce elevated levels of IL-6. We previously generated p62(P394L) knock-in mice (p62KI) and found that although OCL numbers were increased, the mice did not develop pagetic lesions. However, mice expressing both MVNP and p62KI developed more exuberant pagetic lesions than mice expressing MVNP alone. To examine the role of elevated IL-6 in PD and determine if MVNP mediates its effects primarily through elevation of IL-6, we generated transgenic mice that overexpress IL-6 driven by the tartrate-resistant acid phosphatase (TRAP) promoter (TIL-6 mice) and produce IL-6 at levels comparable to MVNP mice. These were crossed with p62KI mice to determine whether IL-6 overexpression cooperates with mutant p62 to produce pagetic lesions. OCL precursors from p62KI/TIL-6 mice formed greater numbers of OCLs than either p62KI or TIL-6 OCL precursors in response to 1,25-(OH)2 D3 . Histomorphometric analysis of bones from p62KI/TIL-6 mice revealed increased OCL numbers per bone surface area compared to wild-type (WT) mice. However, micro-quantitative CT (µQCT) analysis did not reveal significant differences between p62KI/TIL-6 and WT mice, and no pagetic OCLs or lesions were detected in vivo. Thus, increased IL-6 expression in OCLs from p62KI mice contributes to increased responsivity to 1,25-(OH)2 D3 and increased OCL numbers, but is not sufficient to induce Paget's-like OCLs or bone lesions in vivo.

Citing Articles

Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation.

Miyagawa K, Tenshin H, Mulcrone P, Delgado-Calle J, Subler M, Windle J JCI Insight. 2023; 8(14).

PMID: 37338990 PMC: 10443794. DOI: 10.1172/jci.insight.159838.


Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption.

Ethiraj P, Haque I, Alford A, Gou W, Singh T, Sambandam Y J Cell Biochem. 2021; 122(10):1534-1543.

PMID: 34228377 PMC: 8479865. DOI: 10.1002/jcb.30076.


Transgenic inhibition of interleukin-6 trans-signaling does not prevent skeletal pathologies in mucolipidosis type II mice.

Westermann L, Baranowsky A, Di Lorenzo G, Danyukova T, Soul J, Schwartz J Sci Rep. 2021; 11(1):3556.

PMID: 33574442 PMC: 7878873. DOI: 10.1038/s41598-021-82802-3.


Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.

Nagata Y, Miyagawa K, Ohata Y, Petrusca D, Pagnotti G, Mohammad K J Cell Biochem. 2020; 122(3-4):335-348.

PMID: 33107091 PMC: 7887003. DOI: 10.1002/jcb.29861.


Mechanism of Action of Icariin in Bone Marrow Mesenchymal Stem Cells.

Yang A, Yu C, Lu Q, Li H, Li Z, He C Stem Cells Int. 2019; 2019:5747298.

PMID: 31089330 PMC: 6476003. DOI: 10.1155/2019/5747298.


References
1.
Kurihara N, Hiruma Y, Yamana K, Michou L, Rousseau C, Morissette J . Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease. Cell Metab. 2011; 13(1):23-34. PMC: 3025409. DOI: 10.1016/j.cmet.2010.12.002. View

2.
Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B . The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003; 349(26):2483-94. DOI: 10.1056/NEJMoa030847. View

3.
Roodman G, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A . Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest. 1992; 89(1):46-52. PMC: 442817. DOI: 10.1172/JCI115584. View

4.
Hiruma Y, Kurihara N, Subler M, Zhou H, Boykin C, Zhang H . A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment. Hum Mol Genet. 2008; 17(23):3708-19. PMC: 2581430. DOI: 10.1093/hmg/ddn266. View

5.
Kurihara N, Reddy S, Araki N, Ishizuka S, Ozono K, Cornish J . Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease. J Bone Miner Res. 2004; 19(7):1154-64. DOI: 10.1359/JBMR.040312. View